962P Immunotherapeutic implications of mucin 1/16 expression in head and neck squamous cell carcinoma (HNSCC)
Θεόδωρος Ράμπιας(Academy of Athens), A. Psyrri(University General Hospital Attikon), Anastasios Pantazopoulos(University General Hospital Attikon), Evangelos Giotakis(National and Kapodistrian University of Athens), Oikonomopoulou Panagiota(University General Hospital Attikon), Christos K. Kontos(National and Kapodistrian University of Athens), Μaria Anastasiou(National and Kapodistrian University of Athens), George Kavourakis(National and Kapodistrian University of Athens), Ioannis Chatzidakis(University General Hospital Attikon), Ioannis Kotsantis(National and Kapodistrian University of Athens), Andreas Scorilas(National and Kapodistrian University of Athens), S. Golfinopoulos(University General Hospital Attikon), Niki Gavrielatou(National and Kapodistrian University of Athens), A. Polyzos(Cornell University), Periklis Foukas(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
|BMC Medicine|2021|59
Systematic Review of Recurrent Osteosarcoma Systemic Therapy
|Cancers|2021|58
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma
|Annals of Oncology|2023|53
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
|ESMO Open|2021|48
Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling
|Journal of Thoracic Oncology|2022|40